Is it beneficial for patients with pT1‐2N1M0 breast cancer to receive p ostmastectomy radiotherapy? An analysis based on RecurIndex assay-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Is it beneficial for patients with pT1‐2N1M0 breast cancer to receive p ostmastectomy radiotherapy? An analysis based on RecurIndex assay

Published:2021-08-03 Issue:10 Volume:149 Page:1801-1808
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Zhang Lina¹,Zhou Mengli²³,Liu Yueping⁴,Du Furong²³,Tang Jiyu²³,Wang Ning²³,Song Chao²³⁵,Geng Cuizhi¹,Duan Huijun⁶^ORCID

Affiliation:

1. Breast Center The Fourth Hospital of Hebei Medical University Shijiazhuang China

2. State Key Laboratory of Translational Medicine and Innovative Drug Development Jiangsu Simcere Diagnostics Co., Ltd. Nanjing China

3. Department of Medicine Nanjing Simcere Medical Laboratory Science Co., Ltd. Nanjing China

4. Department of Pathology The Fourth Hospital of Hebei Medical University Shijiazhuang China

5. Henan Key Laboratory of Precision Medicine Zhengzhou China

6. Department of Pathology Hebei Medical University Shijiazhuang China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33730

Reference29 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Long-term survival and stage I breast cancer subtypes

3. Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized Trial

4. Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials

5. NCCN Guidelines Insights: Breast Cancer, Version 1.2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RecurIndex-Guided postoperative radiotherapy with or without Avoidance of Irradiation of regional Nodes in 1–3 node-positive breast cancer (RIGAIN): a study protocol for a multicentre, open-label, randomised controlled prospective, phase III trial;BMJ Open;2024-07

2. Advances in regional nodal management of early-stage breast cancer;Chinese Journal of Cancer Research;2024

3. Genetic Testing Enhances the Precision Diagnosis and Treatment of Breast Cancer;International Journal of Molecular Sciences;2023-11-22

4. An Analysis of Clinical and Pathologic Features, RecurIndex Genomic Profiles, and Survival Outcomes in HER2-Low Breast Cancer;The Oncologist;2023-06-06

5. IMNI PRECISION trial protocol: a phase II, open-label, non-inferior randomized controlled trial of tailoring omission of internal mammary node irradiation for early-stage breast cancer;BMC Cancer;2022-12-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3